ciprofloxacin and carbapenems

ciprofloxacin has been researched along with carbapenems in 73 studies

Research

Studies (73)

Timeframe	Studies, this research(%)	All Research%
pre-1990	3 (4.11)	18.7374
1990's	6 (8.22)	18.2507
2000's	18 (24.66)	29.6817
2010's	31 (42.47)	24.3611
2020's	15 (20.55)	2.80

Authors

Authors	Studies
Anderson, DJ	1
Jacobus, NV; Petersen, PJ; Testa, RT; Weiss, WJ	1
Chezzi, C; Leone, F; Menozzi, MG; Molinari, G; Pirali, F; Ravizzola, G; Sanna, A; Schito, GC	1
Chin, NX; Neu, HC	1
Powell, M; Seetulsingh, P; Williams, JD	1
Cipriani, P; Filadoro, F; Giordano, A; Magni, A; Papa, F	1
Eltahawy, AT	1
Babini, GS; Bates, J; Livermore, DM; Palepou, MF; Woodford, N	1
Eliasson, I; Erlandsson, CM; Hanberger, H; Hoffmann, M; Isaksson, B; Lindgren, S; Nilsson, LE; Sörén, L; Walther, SM	1
Jones, RN	1
Beguin, Y; Debouge, MH; Fillet, G; Frère, P; Hermanne, JP	1
Iwashima, A; Kiguchi, T; Sato, K; Yamaguchi, M	1
Burgess, DS; Frei, CR; Moczygemba, LR	1
Fukuda, Y; Kamiyama, T; Mitsuyama, J; Mizunaga, S; Takahata, M	1
Adukauskiene, D; Dudzevicius, V; Ryskus, L; Sakalauskas, R; Vitkauskiene, A	1
Paterson, DL	1
Doi, M; Fujiue, Y; Kuwabara, M; Muroki, K; Shimizu, S; Watanabe, Y; Yano, S	1
Kawano, F; Koga, S; Matsuoka, H; Okamura, S; Shibata, K; Shirahashi, A; Suzushima, H; Tamura, K; Tsukamoto, A; Uozumi, K; Yamashita, K	1
Alp, E; Aygen, B; Metan, G; Sumerkan, B	1
Huang, SS; Lee, MH; Leu, HS	1
Gfröer, S; Knabbe, C; Rahmig, H; Schroeppel, K; Susa, M; Weile, J	1
Carmeli, Y; Chmelnitsky, I; Navon-Venezia, S; Strahilevitz, J	1
Chida, T; Koike, K; Kumita, W; Moriya, K; Ode, T; Okamura, N; Saito, R; Sato, K	1
Pezzilli, R	1
Athanassia, S; Giamarellos-Bourboulis, EJ; Giamarellou, H; Giannitsioti, E; Kanellakopoulou, K; Papadopoulos, A	1
Igarashi, Y; Inui, K; Ohara, H; Ohya, T; Tazuma, S; Tsuyuguchi, T	1
Antinori, S; Antonelli, M; Bernabei, R; Carosi, G; Cataldo, MA; Cauda, R; Corti, G; De Angelis, G; Fadda, G; Mantengoli, E; Pan, A; Paradisi, F; Radice, A; Rossolini, GM; Spanu, T; Stolzuoli, L; Tacconelli, E	1
Flamm, R; Friedland, I; Kaniga, K; Lee, M; Redman, R; Tong, SY	1
Chien, CC; Lee, CH; Li, CC; Liu, JW; Su, LH; Tang, YF	1
Bian, J; Ning, FG; Zhang, GA; Zhao, XZ	1
Alış, EE; Cengiz, M; Ekici, S; Turan, G	1
Anan, N; Ito, A; Nakamura, R; Toba, S; Tsuji, M	1
Firsov, AA; Gilbert, D; Greer, K; Portnoy, YA; Zinner, SH	2
Chiu, CH; Su, LH; Wu, TL	1
Cai, JC; Chen, GX; Hu, YY; Sun, Q; Zhang, R; Zhou, HW	1
Bou, G; Fernández, JL; Fernández, Mdel C; Gosálvez, J; Otero, FM; Santiso, R; Tamayo, M; Tomás, M	1
Bachmann, A; Bonkat, G; Braissant, O; Frei, R; Gasser, TC; Müller, G; Rieken, M; Tschudin-Suter, S; Widmer, AF; Wyler, S	1
Davies, TA; He, W; Lynch, AS; Queenan, AM	1
Bao, Y; Cai, Y; Chai, T; Gao, J; Li, X; Ma, R; Zhao, X; Zhou, Y	1
Chiu, SK; Chuang, YC; Fung, CP; Lin, JC; Lu, PL; Siu, LK; Wang, JT; Wang, LS; Wu, TL; Yeh, KM	1
Akcali, A; Bozkurt-Guzel, C; Ozbek-Celik, B; Savage, PB	1
Bhattacharya, S; Bhaumik, J; Chandy, M; Goel, G; Mukherjee, S	1
Chia, JH; Hsu, PC; Kuo, AJ; Lee, CH; Lee, MH; Su, TY; Ye, JJ	1
Gil-Romero, Y; Gómez-Garcés, JL; Muñoz-Paraíso, C; Regodón-Domínguez, M; Sanz-Rodríguez, N	1
Barnett, AG; Diab, S; Fraser, JF; Fung, YL; Roberts, JA; Shekar, K; Wallis, SC	1
Chen, Y; Gao, W; Li, X; Ouyang, W; Wei, J; Wen, Z; Xue, H	1
Hallböök, H; Lidström, AK; Pauksens, K	1
Al-Agamy, MH; Al-Qahtani, AA; El-Mahdy, TS; Shibl, AM	1
Andreassen, S; Dickstein, Y; Geffen, Y; Leibovici, L; Paul, M	1
Álvarez, C; Ardila, N; Ariza, B; Caro, MA; Gil, F; González, PF; Valderrama, SL	1
Al-Agamy, MH; Courvalin, P; El-Mahdy, TS; Jeannot, K; Kattan, W; Plésiat, P; Shibl, AM	1
Biglari, S; Hanafiah, A; Lopes, BS; Mohd Puzi, S; Rahman, M; Ramli, R	1
Babu Rajendran, N; Burkert, FR; Carmeli, Y; Gkolia, P; Gladstone, BP; Rodríguez-Baño, J; Sifakis, F; Tacconelli, E; Voss, A	1
Blackmore, T; Bloomfield, M	1
Ascher, DB; Cleland, H; Hawkey, J; Holt, KE; Judd, LM; Kostoulias, X; Padiglione, A; Peleg, AY; Spelman, DW; Wick, RR	1
Abbas, HA; Goda, RM; Kadry, AA; Shaker, GH	1
Astocondor, L; Garcia, C; Hinostroza, N; Jacobs, J; Ochoa, T	1
Aller, SD; Bruchmann, S; Clark, T; Coello Pelegrin, A; Cormican, M; Diez Benavente, E; Doyle, RM; Ellington, MJ; Harris, KA; Huggett, JF; McGrath, E; Moran-Gilad, J; Motro, Y; O'Sullivan, DM; Phelan, J; Phuong Thuy Nguyen, T; Shaw, LP; Stabler, RA; van Belkum, A; van Dorp, L; Woodford, N	1
Arevalo-Vidal, E; Baquerizo-Burgos, J; Bunces-Orellana, O; Bustos-Galarza, K; Ferrín-Viteri, M; Oleas, R; Puga-Tejada, M	1
Cao, X; Chang, H; Chen, S; Chen, Y; Hao, Y; Huang, R; Jia, B; Wu, C; Wu, W; Xiong, Y; Yan, X; Zhang, H; Zhang, Z; Zhou, W	1
Goto, K; Itoh, H; Kai, M; Kitano, T; Ohchi, Y; Suzuki, Y; Tanaka, R; Tatsuta, R; Yasuda, N	1
Chomnawang, MT; Houngsaitong, J; Kanathum, P; Khuntayaporn, P; Montakantikul, P; Thirapanmethee, K	1
Abaza, M; Aboubakr, M; Awad, D; Edris, S; Fouad, M; Hamad, A; Hussein, A; Nabil, M; Ramadan, H; Sabeq, I; Shama, S	1
Becerra-Aparicio, F; Fuchs, F; Higgins, PG; Seifert, H; Xanthopoulou, K	1
Deligios, M; Fiamma, M; Paglietti, B; Rubino, S; Sacarlal, J; Santona, A; Simbine, SE; Sumbana, JJ; Taviani, E; Zimba, T	1
Courtois, R; Danneels, P; Dubée, V; Eveillard, M; Kempf, M; Mahieu, R; Quinqueneau, C; Rihet, C; Vannier, C	1
Hayashi, C; Kai, D; Kamoshida, G; Kanda, N; Kaya, Y; Morimoto, H; Nakamura, T; Okada, T; Sakaguchi, M; Sawada, T; Takemoto, N; Yahiro, K; Yamada, N; Yamaguchi, D; Yamashita, M	1
Dong, L; Feng, J; Geng, H; Gu, S; He, C; Hou, G; Ji, T; Kang, W; Lai, J; Li, Y; Li, Z; Pang, D; Wang, Y; Zhao, L; Zhu, X; Zhu, Y	1
Bai, Y; Fan, X; Fu, L; Tian, C; Wang, S; Xing, M; Zhao, Y	1
Almasri, DM; Barnawi, MH; Bulbol, S; Thabit, AK	1
Chacko, S; Maheshwari, TK; Murdeshwar, S; Sheikh, RY	1
Ali, MG; Almoneim, ZA; Kareem, SM	1

Reviews

2 review(s) available for ciprofloxacin and carbapenems

Article	Year
Choosing the right antibacterial agent. Is 'newer' always better? Postgraduate medicine, 1991, Sep-01, Volume: 90, Issue:3 Topics: Anti-Bacterial Agents; Aztreonam; Carbapenems; Ciprofloxacin; Humans; Microbial Sensitivity Tests	1991
Resistance in gram-negative bacteria: enterobacteriaceae. The American journal of medicine, 2006, Volume: 119, Issue:6 Suppl 1 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Carbapenems; Cephalosporins; Ciprofloxacin; Community-Acquired Infections; Drug Resistance, Bacterial; Drug Resistance, Multiple; Enterobacteriaceae; Enterobacteriaceae Infections; Gram-Negative Bacterial Infections; Humans; Klebsiella Infections; Quinolones; Urinary Tract Infections	2006

Article

Year

Choosing the right antibacterial agent. Is 'newer' always better?

Postgraduate medicine, 1991, Sep-01, Volume: 90, Issue:3

Topics: Anti-Bacterial Agents; Aztreonam; Carbapenems; Ciprofloxacin; Humans; Microbial Sensitivity Tests

1991

Resistance in gram-negative bacteria: enterobacteriaceae.

The American journal of medicine, 2006, Volume: 119, Issue:6 Suppl 1

Topics: Anti-Bacterial Agents; Anti-Infective Agents; Carbapenems; Cephalosporins; Ciprofloxacin; Community-Acquired Infections; Drug Resistance, Bacterial; Drug Resistance, Multiple; Enterobacteriaceae; Enterobacteriaceae Infections; Gram-Negative Bacterial Infections; Humans; Klebsiella Infections; Quinolones; Urinary Tract Infections

2006

Trials

3 trial(s) available for ciprofloxacin and carbapenems

Article	Year
In-vitro activity of meropenem against clinical isolates in a multicentre study in Italy. The Journal of antimicrobial chemotherapy, 1989, Volume: 24 Suppl A Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Carbapenems; Ciprofloxacin; Gram-Negative Aerobic Bacteria; Gram-Negative Anaerobic Bacteria; Humans; Italy; Meropenem; Microbial Sensitivity Tests; Multicenter Studies as Topic; Thienamycins	1989
Efficacy of intravenous ciprofloxacin in patients with febrile neutropenia refractory to initial therapy. Leukemia & lymphoma, 2006, Volume: 47, Issue:8 Topics: Adult; Aged; Algorithms; Carbapenems; Cefepime; Cephalosporins; Ciprofloxacin; Female; Fever; Hematologic Diseases; Humans; Male; Middle Aged; Neutropenia; Remission Induction; Salvage Therapy; Treatment Failure; Treatment Outcome	2006
Clinical efficacy of intravenous ciprofloxacin in patients with biliary tract infection: a randomized controlled trial with carbapenem as comparator. Journal of gastroenterology, 2009, Volume: 44, Issue:7 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Bile Duct Diseases; Carbapenems; Ciprofloxacin; Drug Evaluation; Female; Humans; Infusions, Intravenous; Male	2009

Other Studies

68 other study(ies) available for ciprofloxacin and carbapenems

Article	Year
In vitro and in vivo activities of LJC10,627, a new carbapenem with stability to dehydropeptidase I. Antimicrobial agents and chemotherapy, 1991, Volume: 35, Issue:1 Topics: Amikacin; Animals; Bacterial Infections; Bacteroides fragilis; Carbapenems; Ceftazidime; Cilastatin; Ciprofloxacin; Dipeptidases; Drug Therapy, Combination; Escherichia coli; Female; Imipenem; Klebsiella pneumoniae; Metronidazole; Mice; Microbial Sensitivity Tests; Piperacillin; Pseudomonas aeruginosa; Staphylococcus; Streptococcus; Thienamycins	1991
In-vitro activity of FCE 22101 and synergy studies with other antimicrobial agents. The Journal of antimicrobial chemotherapy, 1989, Volume: 23 Suppl C Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Ciprofloxacin; Drug Resistance, Microbial; Drug Synergism; Gentamicins; Gram-Positive Bacteria; Microbial Sensitivity Tests	1989
In-vitro susceptibility of Haemophilus influenzae to meropenem compared with imipenem, five other beta-lactams, chloramphenicol and ciprofloxacin. The Journal of antimicrobial chemotherapy, 1989, Volume: 24 Suppl A Topics: Ampicillin; Anti-Bacterial Agents; Carbapenems; Chloramphenicol; Ciprofloxacin; Culture Media; Haemophilus influenzae; Imipenem; Meropenem; Microbial Sensitivity Tests; Penicillin Resistance; Thienamycins	1989
Outer membrane alterations in Pseudomonas aeruginosa after five-day exposure to quinolones and carbapenems. Drugs under experimental and clinical research, 1995, Volume: 21, Issue:4 Topics: Anti-Infective Agents; Bacterial Outer Membrane Proteins; Carbapenems; Cell Membrane; Ciprofloxacin; Fluoroquinolones; Imipenem; Lipopolysaccharides; Meropenem; Microbial Sensitivity Tests; Naphthyridines; Pseudomonas aeruginosa; Thienamycins; Time Factors	1995
Gram-negative bacilli isolated from patients in intensive care unit: prevalence and antibiotic susceptibility. Journal of chemotherapy (Florence, Italy), 1997, Volume: 9, Issue:6 Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Blood; Carbapenems; Cephalosporins; Ciprofloxacin; Cross Infection; Drug Resistance, Microbial; Gram-Negative Bacteria; Humans; Imipenem; Intensive Care Units; Microbial Sensitivity Tests; Respiratory Tract Infections; Saudi Arabia; Urinary Tract Infections; Wounds and Injuries	1997
Carbapenemase-producing Pseudomonas aeruginosa in UK. Lancet (London, England), 1998, Aug-15, Volume: 352, Issue:9127 Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Ceftazidime; Ciprofloxacin; Drug Resistance, Microbial; Enzyme Inhibitors; Gentamicins; Humans; Imipenem; Meropenem; Metalloproteins; Penicillanic Acid; Penicillins; Piperacillin; Pseudomonas aeruginosa; Tazobactam; Thienamycins; United Kingdom	1998
Surveillance of antibiotic resistance in ICUs in southeastern Sweden. ICU Study Group of the South East of Sweden. Acta anaesthesiologica Scandinavica, 1999, Volume: 43, Issue:8 Topics: Ampicillin Resistance; Anti-Bacterial Agents; Anti-Infective Agents; APACHE; Bacteria; Carbapenems; Cefotaxime; Cephalosporins; Ciprofloxacin; Critical Care; Drug Resistance, Microbial; Drug Utilization; Enterococcus faecalis; Enterococcus faecium; Escherichia coli; Fusidic Acid; Gentamicins; Humans; Netilmicin; Oxacillin; Penicillin Resistance; Penicillins; Population Surveillance; Prevalence; Staphylococcus; Sweden	1999
In vitro evaluation of ertapenem (MK-0826), a long-acting carbapenem, tested against selected resistant strains. Journal of chemotherapy (Florence, Italy), 2001, Volume: 13, Issue:4 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Carbapenems; Ciprofloxacin; Drug Evaluation; Drug Resistance; Drug Synergism; Gentamicins; Gram-Negative Aerobic Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Molecular Structure; Phenotype	2001
Changing pattern of bacterial susceptibility to antibiotics in hematopoietic stem cell transplant recipients. Bone marrow transplantation, 2002, Volume: 29, Issue:7 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Bacterial Infections; Belgium; Carbapenems; Cephalosporins; Ciprofloxacin; Drug Resistance; Drug Resistance, Multiple, Bacterial; Enterococcus; Follow-Up Studies; Gram-Negative Bacteria; Hematopoietic Stem Cell Transplantation; Humans; Microbial Sensitivity Tests; Retrospective Studies; Staphylococcus; Streptococcus; Transplantation, Autologous; Transplantation, Homologous	2002
[Isolation-frequency and antibiotic susceptibility of Streptococcus pneumoniae, Haemophilus influenzae, and Pseudomonas aeruginosa isolated in regional core hospitals in the Nagaoka district of Niigata Prefecture (changes for 3 years)]. The Japanese journal of antibiotics, 2004, Volume: 57, Issue:1 Topics: Anti-Infective Agents; Carbapenems; Ciprofloxacin; Drug Resistance, Bacterial; Haemophilus influenzae; Hospitals, Urban; Humans; Japan; Levofloxacin; Ofloxacin; Penicillin G; Pseudomonas aeruginosa; Streptococcus pneumoniae; Time Factors	2004
Pharmacodynamic modeling of carbapenems and fluoroquinolones against bacteria that produce extended-spectrum beta-lactamases. Clinical therapeutics, 2004, Volume: 26, Issue:11 Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Ciprofloxacin; Drug Resistance, Bacterial; Ertapenem; Escherichia coli; Fluoroquinolones; Gatifloxacin; Humans; Imipenem; Klebsiella pneumoniae; Lactams; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Models, Biological; Monte Carlo Method; Ofloxacin; Thienamycins	2004
Influence of inoculum size of Staphylococcus aureus and Pseudomonas aeruginosa on in vitro activities and in vivo efficacy of fluoroquinolones and carbapenems. The Journal of antimicrobial chemotherapy, 2005, Volume: 56, Issue:1 Topics: Animals; Carbapenems; Ciprofloxacin; Fluoroquinolones; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Oxazines; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcal Infections; Staphylococcus aureus	2005
[The rate of isolation of Klebsiella pneumoniae producing extended-spectrum beta-lactamases and resistance to antibiotics]. Medicina (Kaunas, Lithuania), 2006, Volume: 42, Issue:4 Topics: Amikacin; Anti-Bacterial Agents; beta-Lactamases; Bronchi; Carbapenems; Cephalosporins; Ciprofloxacin; Gentamicins; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Piperacillin	2006
[Antimicrobial susceptibility of Pseudomonas aeruginosa isolated from urine at one hospital to mainly carbapenem and fluoroquinolone drugs]. The Japanese journal of antibiotics, 2006, Volume: 59, Issue:2 Topics: Amikacin; Anti-Infective Agents; Carbapenems; Ceftazidime; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Humans; Imipenem; Meropenem; Oxazines; Piperacillin; Pseudomonas aeruginosa; Thienamycins; Urine	2006
Carbapenem-resistant Acinetobacter baumannii: an emerging threat for patients with post-neurosurgical meningitis. International journal of antimicrobial agents, 2007, Volume: 29, Issue:1 Topics: Acinetobacter baumannii; Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Carbapenems; Cefepime; Cefoperazone; Cephalosporins; Ciprofloxacin; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Male; Meningitis, Bacterial; Meropenem; Microbial Sensitivity Tests; Middle Aged; Neurosurgical Procedures; Postoperative Complications; Thienamycins; Turkey	2007
Bacteremia due to extended-spectrum beta-lactamase-producing Enterobacteriaceae other than Escherichia coli and Klebsiella. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2006, Volume: 39, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Ceftazidime; Ciprofloxacin; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Female; Humans; Klebsiella; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Survival Rate; Taiwan; Treatment Outcome	2006
First detection of a VIM-1 metallo-beta-lactamase in a carbapenem-resistant Citrobacter freundii clinical isolate in an acute hospital in Germany. Scandinavian journal of infectious diseases, 2007, Volume: 39, Issue:3 Topics: Aged, 80 and over; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cilastatin; Ciprofloxacin; Citrobacter freundii; Enterobacteriaceae Infections; Female; Germany; Humans; Imipenem; Polymerase Chain Reaction	2007
Plasmid-mediated qnrB2 and carbapenemase gene bla(KPC-2) carried on the same plasmid in carbapenem-resistant ciprofloxacin-susceptible Enterobacter cloacae isolates. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:8 Topics: Anti-Infective Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Ciprofloxacin; Drug Resistance, Bacterial; Enterobacter cloacae; Genes, Bacterial; Microbial Sensitivity Tests; Plasmids; Quinolones	2008
Molecular characterizations of carbapenem and ciprofloxacin resistance in clinical isolates of Pseudomonas putida. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2009, Volume: 15, Issue:1 Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Ciprofloxacin; DNA Topoisomerase IV; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Integrases; Microbial Sensitivity Tests; Polymerase Chain Reaction; Porins; Pseudomonas putida	2009
Antibiotic prophylaxis in severe acute pancreatitis: do we need more meta-analytic studies? JOP : Journal of the pancreas, 2009, Mar-09, Volume: 10, Issue:2 Topics: Acute Disease; Antibiotic Prophylaxis; Carbapenems; Cefuroxime; Ciprofloxacin; Humans; Meta-Analysis as Topic; Metronidazole; Ofloxacin; Pancreatitis; Randomized Controlled Trials as Topic	2009
Chronic bone infections due to Enterobacter cloacae: current therapeutic trends and clinical outcome. Journal of chemotherapy (Florence, Italy), 2009, Volume: 21, Issue:2 Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bone Diseases, Infectious; Carbapenems; Chronic Disease; Ciprofloxacin; Combined Modality Therapy; Debridement; Drug Resistance, Multiple, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged; Retrospective Studies; Young Adult	2009
Antibiotic usage and risk of colonization and infection with antibiotic-resistant bacteria: a hospital population-based study. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:10 Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Ciprofloxacin; Cohort Studies; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterococcus; Female; Hospitals; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Pseudomonas aeruginosa; Vancomycin Resistance	2009
Worldwide experience with the use of doripenem against extended-spectrum-beta-lactamase-producing and ciprofloxacin-resistant Enterobacteriaceae: analysis of six phase 3 clinical studies. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:5 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Ciprofloxacin; Clinical Trials, Phase III as Topic; Doripenem; Enterobacteriaceae; Enterobacteriaceae Infections; Global Health; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prevalence	2010
Microbiologic and clinical implications of bacteremia due to extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae with or without plasmid-mediated AmpC beta-lactamase DHA-1. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenems; Case-Control Studies; Ciprofloxacin; Female; Humans; Klebsiella pneumoniae; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Plasmids; Young Adult	2010
Large-area burns with pandrug-resistant Pseudomonas aeruginosa infection and respiratory failure. Chinese medical journal, 2011, Volume: 124, Issue:3 Topics: Adolescent; Adult; Anti-Bacterial Agents; Burns; Carbapenems; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Female; Humans; Macrolides; Male; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Insufficiency; Retrospective Studies; Young Adult	2011
Fluoroquinolone-resistant acute prostatitis requiring hospitalization after transrectal prostate biopsy: effect of previous fluoroquinolone use as prophylaxis or long-term treatment. International urology and nephrology, 2012, Volume: 44, Issue:1 Topics: Aged; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotic Prophylaxis; Biopsy; Carbapenems; Ceftriaxone; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Enterococcus; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Hospitalization; Humans; Length of Stay; Male; Middle Aged; Prostate; Prostate-Specific Antigen; Prostatitis; Retrospective Studies; Vancomycin	2012
[In vitro combination effects of doripenem with aminoglycoside or ciprofloxacin against Pseudomonas aeruginosa]. The Japanese journal of antibiotics, 2011, Volume: 64, Issue:4 Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Carbapenems; Ciprofloxacin; Doripenem; Drug Combinations; Drug Resistance, Bacterial; Drug Synergism; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Tobramycin	2011
Comparative pharmacodynamics and antimutant potentials of doripenem and imipenem with ciprofloxacin-resistant Pseudomonas aeruginosa in an in vitro model. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:3 Topics: Anti-Bacterial Agents; Area Under Curve; Carbapenems; Ciprofloxacin; Doripenem; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Humans; Imipenem; Microbial Sensitivity Tests; Models, Biological; Mutation; Predictive Value of Tests; Pseudomonas aeruginosa; Pseudomonas Infections	2012
Development of carbapenem resistance during therapy for non-typhoid Salmonella infection. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2012, Volume: 18, Issue:4 Topics: Aged; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Ertapenem; Feces; Female; Humans; Microbial Sensitivity Tests; Plasmids; Point Mutation; Porins; RNA, Bacterial; Salmonella Infections; Salmonella typhimurium; Urinary Tract Infections; Wound Infection	2012
Emergence of Proteus mirabilis harboring blaKPC-2 and qnrD in a Chinese Hospital. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:5 Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; China; Ciprofloxacin; Clone Cells; Conjugation, Genetic; Cross Infection; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Genes, Bacterial; Humans; Plasmids; Polymerase Chain Reaction; Proteus Infections; Proteus mirabilis; Quinolones; Sequence Analysis, DNA	2012
Fast assessment of resistance to carbapenems and ciprofloxacin of clinical strains of Acinetobacter baumannii. Journal of clinical microbiology, 2012, Volume: 50, Issue:11 Topics: Acinetobacter baumannii; Acinetobacter Infections; Carbapenems; Ciprofloxacin; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests	2012
Concentration-resistance relationships with Pseudomonas aeruginosa exposed to doripenem and ciprofloxacin in an in vitro model. The Journal of antimicrobial chemotherapy, 2013, Volume: 68, Issue:4 Topics: Anti-Bacterial Agents; Carbapenems; Ciprofloxacin; Doripenem; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Mutation; Pseudomonas aeruginosa; Time Factors	2013
Increasing prevalence of ciprofloxacin resistance in extended-spectrum-β-lactamase-producing Escherichia coli urinary isolates. World journal of urology, 2013, Volume: 31, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Ciprofloxacin; Contraindications; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Fosfomycin; Humans; Male; Middle Aged; Nitrofurantoin; Prevalence; Retrospective Studies; Treatment Failure; Treatment Outcome; Urinary Tract; Urinary Tract Infections; Young Adult	2013
Assessment of the combination of doripenem plus a fluoroquinolone against non-susceptible Acinetobacter baumannii isolates from nosocomial pneumonia patients. Journal of chemotherapy (Florence, Italy), 2013, Volume: 25, Issue:3 Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Carbapenems; Ciprofloxacin; Doripenem; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Drug Synergism; Drug Therapy, Combination; Female; Levofloxacin; Mice; Ofloxacin; Pneumonia, Ventilator-Associated; Random Allocation; Survival Analysis	2013
Antibiotic resistance and OXA-type carbapenemases-encoding genes in airborne Acinetobacter baumannii isolated from burn wards. Burns : journal of the International Society for Burn Injuries, 2014, Volume: 40, Issue:2 Topics: Acinetobacter baumannii; Air Microbiology; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Burn Units; Carbapenems; Cefoperazone; Ceftriaxone; Ciprofloxacin; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Microbial Sensitivity Tests; Polymerase Chain Reaction; Repetitive Sequences, Nucleic Acid; Sulbactam	2014
National surveillance study on carbapenem non-susceptible Klebsiella pneumoniae in Taiwan: the emergence and rapid dissemination of KPC-2 carbapenemase. PloS one, 2013, Volume: 8, Issue:7 Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cefazolin; Cefotaxime; Cefoxitin; Ceftazidime; Ciprofloxacin; Klebsiella pneumoniae; Microbial Sensitivity Tests; Taiwan	2013
Potential synergy activity of the novel ceragenin, CSA-13, against carbapenem-resistant Acinetobacter baumannii strains isolated from bacteremia patients. BioMed research international, 2014, Volume: 2014 Topics: Acinetobacter baumannii; Carbapenems; Ciprofloxacin; Cross Infection; Drug Resistance, Bacterial; Drug Synergism; Humans; Microbial Sensitivity Tests; Steroids	2014
Epidemiology of antimicrobial resistance in an oncology center in eastern India. Infection control and hospital epidemiology, 2015, Volume: 36, Issue:7 Topics: Acinetobacter; Amikacin; Anti-Bacterial Agents; Antifungal Agents; Bacterial Infections; Cancer Care Facilities; Carbapenems; Ceftazidime; Ciprofloxacin; Clindamycin; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Enterobacteriaceae; Feces; Fluconazole; Gentamicins; Humans; India; Methicillin-Resistant Staphylococcus aureus; Mycoses; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas; Yeasts	2015
Risk factors and clinical significance of bacteremia caused by Pseudomonas aeruginosa resistant only to carbapenems. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2017, Volume: 50, Issue:5 Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Blood Culture; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Case-Control Studies; Cephalosporins; Ciprofloxacin; Cross Infection; Female; Hospitals; Humans; Imipenem; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Mortality; Multivariate Analysis; Odds Ratio; Penicillins; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Risk Factors; Severity of Illness Index; Taiwan; Thienamycins	2017
[In vitro activity of fosfomycin, alone or in combination, against clinical isolates of carbapenem resistant Pseudomonas aeruginosa]. Enfermedades infecciosas y microbiologia clinica, 2016, Volume: 34, Issue:4 Topics: Anti-Bacterial Agents; Carbapenems; Ciprofloxacin; Drug Resistance, Bacterial; Drug Synergism; Fosfomycin; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa	2016
Can physicochemical properties of antimicrobials be used to predict their pharmacokinetics during extracorporeal membrane oxygenation? Illustrative data from ovine models. Critical care (London, England), 2015, Dec-15, Volume: 19 Topics: Animals; Anti-Infective Agents; Carbapenems; Caspofungin; Ceftriaxone; Ciprofloxacin; Critical Illness; Doripenem; Echinocandins; Extracorporeal Membrane Oxygenation; Fluconazole; Gentamicins; Lipopeptides; Meropenem; Models, Theoretical; Sheep; Sheep, Domestic; Thienamycins; Vancomycin	2015
Clinical characteristics and antimicrobial patterns in complicated intra-abdominal infections: a 6-year epidemiological study in southern China. International journal of antimicrobial agents, 2016, Volume: 47, Issue:3 Topics: Anti-Bacterial Agents; Carbapenems; China; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Enterococcus faecalis; Epidemiologic Studies; Escherichia coli; Female; Gentamicins; Humans; Intraabdominal Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Tazobactam; Treatment Outcome	2016
Ciprofloxacin prophylaxis delays initiation of broad-spectrum antibiotic therapy and reduces the overall use of antimicrobial agents during induction therapy for acute leukaemia: A single-centre study. Infectious diseases (London, England), 2016, Volume: 48, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Bacterial Infections; Carbapenems; Ciprofloxacin; Cohort Studies; Febrile Neutropenia; Female; Humans; Leukemia; Male; Middle Aged; Mycoses	2016
Detection of bla Microbial drug resistance (Larchmont, N.Y.), 2017, Volume: 23, Issue:1 Topics: Acinetobacter baumannii; Acinetobacter Infections; Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Gene Expression Regulation, Bacterial; Gene Transfer, Horizontal; Humans; Microbial Sensitivity Tests; Minocycline; Phylogeny; Plasmids; Polymerase Chain Reaction; Prevalence; Public Health Surveillance; Saudi Arabia; Tigecycline	2017
Predicting Antibiotic Resistance in Urinary Tract Infection Patients with Prior Urine Cultures. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:8 Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Retrospective Studies; Urinary Tract Infections; Urine	2016
Risk factors for hospital-acquired bacteremia due to carbapenem-resistant Pseudomonas aeruginosa in a Colombian hospital. Biomedica : revista del Instituto Nacional de Salud, 2016, Feb-23, Volume: 36, Issue:0 Topics: Bacteremia; beta-Lactams; Carbapenems; Case-Control Studies; Ciprofloxacin; Drug Resistance, Bacterial; Ertapenem; Hospitals; Humans; Meropenem; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Factors; Thienamycins	2016
First Detection of GES-5 Carbapenemase-Producing Acinetobacter baumannii Isolate. Microbial drug resistance (Larchmont, N.Y.), 2017, Volume: 23, Issue:5 Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cephalosporins; Ciprofloxacin; Clone Cells; Colistin; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Gene Expression; Hospitals; Humans; Isoenzymes; Microbial Sensitivity Tests; Minocycline; Molecular Epidemiology; Multilocus Sequence Typing; Saudi Arabia; Serogroup; Tigecycline	2017
Antimicrobial Resistance Mechanisms and Genetic Diversity of Multidrug-Resistant Acinetobacter baumannii Isolated from a Teaching Hospital in Malaysia. Microbial drug resistance (Larchmont, N.Y.), 2017, Volume: 23, Issue:5 Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cephalosporins; Ciprofloxacin; Clone Cells; Cross Infection; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Multiple, Bacterial; Gene Expression; Hospitals, Teaching; Humans; Isoenzymes; Malaysia; Microbial Sensitivity Tests; Multilocus Sequence Typing; Mutation; Plasmids; Sequence Analysis, DNA	2017
EpideMiology and control measures of outBreaks due to Antibiotic-Resistant orGanisms in EurOpe (EMBARGO): a systematic review protocol. BMJ open, 2017, 01-05, Volume: 7, Issue:1 Topics: Acinetobacter baumannii; Bacterial Infections; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Ceftazidime; Ciprofloxacin; Disease Outbreaks; Drug Resistance, Bacterial; Enterobacteriaceae; Escherichia coli; Europe; Humans; Klebsiella pneumoniae; Methicillin-Resistant Staphylococcus aureus; Pseudomonas aeruginosa; Research Design; Systematic Reviews as Topic; Vancomycin-Resistant Enterococci	2017
Prophylactic ciprofloxacin for prostate biopsy: a losing bet? Nature reviews. Urology, 2017, Volume: 14, Issue:11 Topics: Anti-Bacterial Agents; Biopsy; Carbapenems; Ciprofloxacin; Humans; Male; Prostate; Sepsis	2017
Evolution of carbapenem resistance in Acinetobacter baumannii during a prolonged infection. Microbial genomics, 2018, Volume: 4, Issue:3 Topics: Acinetobacter baumannii; Bacterial Proteins; beta-Lactamases; Carbapenems; Ciprofloxacin; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Humans; Membrane Transport Proteins; Meropenem; Microbial Sensitivity Tests; Multilocus Sequence Typing; Polymorphism, Single Nucleotide; Protein Conformation; Sequence Analysis, DNA	2018
Impact of specific inhibitors on metallo-β-carbapenemases detected in Escherichia coli and Klebsiella pneumoniae isolates. Microbial pathogenesis, 2019, Volume: 132 Topics: Anti-Bacterial Agents; Ascorbic Acid; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Catalytic Domain; Ciprofloxacin; Citric Acid; Drug Combinations; Drug Synergism; Escherichia coli; Humans; Imipenem; Klebsiella pneumoniae; Malates; Meropenem; Microbial Sensitivity Tests; Zinc	2019
Characterization of ESBL-Producing The American journal of tropical medicine and hygiene, 2019, Volume: 101, Issue:4 Topics: Adolescent; Anti-Bacterial Agents; Bacteremia; Carbapenems; Child; Child, Preschool; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Hospitals; Humans; Infant; Microbial Sensitivity Tests; Peru; Salmonella; Salmonella enterica; Salmonella Infections; Serogroup	2019
Discordant bioinformatic predictions of antimicrobial resistance from whole-genome sequencing data of bacterial isolates: an inter-laboratory study. Microbial genomics, 2020, Volume: 6, Issue:2 Topics: Anti-Bacterial Agents; Bacteria; Carbapenems; Ciprofloxacin; Computational Biology; Drug Resistance, Bacterial; Genome, Bacterial; Humans; Microbial Sensitivity Tests	2020
Carbapenems versus ciprofloxacin/metronidazole for decreasing complications and hospital stay following complicated acute appendicitis surgery: A prospective cohort in an Ecuadorian population. Cirugia y cirujanos, 2020, Volume: 88, Issue:3 Topics: Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Appendectomy; Appendicitis; Carbapenems; Ciprofloxacin; Comorbidity; Drug Therapy, Combination; Ecuador; Emergencies; Female; Humans; Length of Stay; Male; Metronidazole; Middle Aged; Postoperative Complications; Prospective Studies; Sepsis; Young Adult	2020
Temporal association between carbapenems usage and antimicrobial resistance in gram-negative bacteria at a tertiary hospital in Nanjing, China. Diagnostic microbiology and infectious disease, 2020, Volume: 98, Issue:2 Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Carbapenems; Ceftazidime; China; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Drug Utilization; Escherichia coli; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Inpatients; Microbial Sensitivity Tests; Retrospective Studies; Tertiary Care Centers	2020
Simultaneous quantification of plasma levels of 12 antimicrobial agents including carbapenem, anti-methicillin-resistant Staphylococcus aureus agent, quinolone and azole used in intensive care unit using UHPLC-MS/MS method. Clinical biochemistry, 2021, Volume: 90 Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Azoles; Carbapenems; Chromatography, High Pressure Liquid; Ciprofloxacin; Daptomycin; Doripenem; Drug Monitoring; Female; Fluconazole; Fluoroquinolones; Humans; Intensive Care Units; Levofloxacin; Linezolid; Male; Meropenem; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Oxazines; Oxazolidinones; Quinolones; Tandem Mass Spectrometry; Tetrazoles; Voriconazole	2021
Predominance of international clone 2 multidrug-resistant Acinetobacter baumannii clinical isolates in Thailand: a nationwide study. Annals of clinical microbiology and antimicrobials, 2021, Mar-20, Volume: 20, Issue:1 Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Ciprofloxacin; Clone Cells; Colistin; Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing; Thailand	2021
Prevalence and molecular characterization of foodborne and human-derived Salmonella strains for resistance to critically important antibiotics. Transboundary and emerging diseases, 2022, Volume: 69, Issue:5 Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Cattle; Cephalosporins; Ciprofloxacin; Colistin; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Monobactams; Prevalence; Rabbits; Salmonella; Salmonella enterica; Tetracyclines	2022
In vitro activity of nitroxoline against carbapenem-resistant Acinetobacter baumannii isolated from the urinary tract. The Journal of antimicrobial chemotherapy, 2022, 06-29, Volume: 77, Issue:7 Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Ciprofloxacin; Escherichia coli; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Nitroquinolines; Sulfamethoxazole; Trimethoprim; Urinary Tract; Urinary Tract Infections	2022
High-risk lineages among extended-spectrum β-lactamase-producing Escherichia coli from extraintestinal infections in Maputo Central Hospital, Mozambique. International journal of antimicrobial agents, 2022, Volume: 60, Issue:4 Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cefotaxime; Ceftazidime; Ciprofloxacin; Clavulanic Acid; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Extraintestinal Pathogenic Escherichia coli; Gentamicins; Hospitals; Humans; Iron; Mozambique; Piperacillin; Tazobactam; Trimethoprim, Sulfamethoxazole Drug Combination	2022
Cefoxitin-based combination for ESBL-producing Enterobacteriaceae endocarditis. Infectious diseases now, 2022, Volume: 52, Issue:7 Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cefoxitin; Cilastatin, Imipenem Drug Combination; Ciprofloxacin; Endocarditis; Enterobacteriaceae; Escherichia coli; Escherichia coli Infections; Fosfomycin; Humans; Microbial Sensitivity Tests; Urinary Tract Infections	2022
Preferential Selection of Low-Frequency, Lipopolysaccharide-Modified, Colistin-Resistant Mutants with a Combination of Antimicrobials in Acinetobacter baumannii. Microbiology spectrum, 2022, 10-26, Volume: 10, Issue:5 Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Ciprofloxacin; Colistin; Disinfectants; Drug Resistance, Multiple, Bacterial; Humans; Lipopolysaccharides; Meropenem; Microbial Sensitivity Tests	2022
Drug resistance characteristics and molecular typing of Escherichia coli isolates from neonates in class A tertiary hospitals: A multicentre study across China. The Journal of infection, 2022, Volume: 85, Issue:5 Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactamases; Carbapenems; Cefotaxime; Child; Ciprofloxacin; Doxycycline; Drug Resistance; Escherichia coli; Escherichia coli Infections; Female; Humans; Infant, Newborn; Microbial Sensitivity Tests; Multilocus Sequence Typing; Piperacillin; Pregnancy; Tazobactam; Tertiary Care Centers; Trimethoprim, Sulfamethoxazole Drug Combination	2022
Whole genome sequencing of OXA-232-producing Frontiers in cellular and infection microbiology, 2022, Volume: 12 Topics: Amikacin; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Chromosomes; Ciprofloxacin; DNA Transposable Elements; Ertapenem; Humans; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Multilocus Sequence Typing; Phylogeny; Plasmids; Sepsis; Virulence; Virulence Factors; Whole Genome Sequencing	2022
Clinical and cost-effectiveness analysis of carbapenems versus ciprofloxacin in the treatment of urinary tract infections due to extended spectrum β-lactamase-producing Enterobacterales. European journal of clinical pharmacology, 2023, Volume: 79, Issue:3 Topics: Adult; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Ciprofloxacin; Cost-Effectiveness Analysis; Female; Humans; Pregnancy; Retrospective Studies; Urinary Tract Infections	2023
Microbiological Spectrum and Antibiogram of Urinary Tract Infection in a Tertiary Care Center from the Kingdom of Bahrain. Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia, 2022, Volume: 33, Issue:Supplement Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bahrain; beta-Lactamases; Carbapenems; Ciprofloxacin; Escherichia coli; Female; Humans; Klebsiella pneumoniae; Levofloxacin; Male; Microbial Sensitivity Tests; Retrospective Studies; Tertiary Care Centers; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections	2022
Evaluated gene expressions of Metallo beta lactamase genes GIM and , VIM, SPM in Pseudomonas aeruginosa clinical isolates. Molecular biology reports, 2023, Volume: 50, Issue:12 Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Child; Ciprofloxacin; Gene Expression; Humans; Microbial Sensitivity Tests; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections; Real-Time Polymerase Chain Reaction; RNA, Ribosomal, 16S	2023